Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Hodgkin Disease 50 Lymphoma 45 Testicular Neoplasms 13 Teratoma 12 HIV Infections 12 Acquired Immunodeficiency Syndrome 11 Lymphoma, Large B-Cell, Diffuse 10 Lymphoma, Non-Hodgkin 9 Head and Neck Neoplasms 8 Endodermal Sinus Tumor 8 Testicular Germ Cell Tumor 7 Sarcoma, Kaposi 7 Neoplasms 7 Carcinoma, Embryonal 7 Seminoma 6 Lymphoma, Large-Cell, Immunoblastic 6 Lymphoma, Follicular 6 Ovarian Neoplasms 5 Ovarian Germ Cell Cancer 5 Recurrence 4 Neoplasms, Germ Cell and Embryonal 4 Neoplasm Metastasis 4 Carcinoma, Squamous Cell 4 Vulvar Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 3 Teratoma, Testicular 2 Skin Neoplasms 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Drug-Related Side Effects and Adverse Reactions 2 Dendritic Cell Sarcoma, Interdigitating 2

Interventions

Pharmaceutical Preparations 1 Electroporation 1 Electrochemotherapy 1 Cisplatin 1 Bleomycin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Gynecological Cancers × Bleomycin × Clear all

NCT04760327 2024-10-17

GynECT

Institute of Oncology Ljubljana

Phase 2 Recruiting

Gynecological Cancers

Data powered by HemOnc (CC BY 4.0) Colophon ⚡